Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

Financial Services Healthcare Asset Management
PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all... see more

Recent & Breaking News (TSXV:PCLO)

PharmaCielo Ltd. Announces Closing of Previously Announced $8 Million Private Placement Financing

Canada NewsWire April 15, 2020

PharmaCielo Ltd. Prices $8 Million Offering; Closing Scheduled for April 14

Canada NewsWire April 6, 2020

PharmaCielo Ltd. Announces Best Efforts Private Placement Offering

Canada NewsWire April 1, 2020

PharmaCielo Independent Investigation Concludes Short-seller Report Contains Accusations and Claims based on Faulty Interpretation of Events and Information

Canada NewsWire March 23, 2020

PharmaCielo Issues Statement Regarding Misleading Short Seller Report

Canada NewsWire March 3, 2020

XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market

Newsfile January 27, 2020

PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market

Canada NewsWire January 27, 2020

PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil

Canada NewsWire January 24, 2020

PharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index

Canada NewsWire January 22, 2020

PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations

Canada NewsWire January 20, 2020

PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill Compliant CBD Isolate to United States

Canada NewsWire January 17, 2020

PharmaCielo Awarded Game-Changer Award by MJDaily

Canada NewsWire December 14, 2019

PharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment

Canada NewsWire December 5, 2019

OTC Markets Group Welcomes PharmaCielo Ltd. to OTCQX

PR Newswire December 2, 2019

PharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility

Canada NewsWire December 2, 2019

PharmaCielo to Hold Conference Call to Review Third Quarter 2019 Financial Results

Canada NewsWire November 25, 2019

PharmaCielo Announces Financial Results for the Three and Nine Months Ended September 30, 2019

Canada NewsWire November 25, 2019

PharmaCielo Announces RSU Grant

Canada NewsWire November 8, 2019

IIROC Trading Resumption - PCLO

Canada NewsWire November 6, 2019

PharmaCielo Announces Termination of Scheme Implementation Agreement with Creso Pharma

Canada NewsWire November 5, 2019